Stablepoint Partners, LLC

Position in JNJ — Johnson & Johnson

CIK 2011237 BRAINTREE, MA

Position in JNJ

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$7,606,401

+$332,600 QoQ

Shares Held

29,950

+0.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#1,288

of 4,664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stablepoint Partners, LLC holds $55,827,894 across 12 Drug Manufacturers - General names. JNJ ranks #3 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,144	$11,277,865
2	MRK	Merck & Co., Inc.	67,206	$8,635,971
3	JNJ	Johnson & Johnson This page	29,950	$7,606,401
4	GSK	GSK plc	109,711	$5,751,050
5	ABBV	AbbVie Inc.	21,670	$5,453,038
6	PFE	Pfizer Inc	201,036	$4,840,946
7	LLY	ELI LILLY & Co	3,240	$3,886,153
8	GILD	Gilead Sciences, Inc.	23,047	$2,911,757

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,606,401	29,950	+0.6%	Shares	Sole	2026-07-09
2026-03-31	$7,273,801	29,757	-15.6%	Shares	Sole	2026-04-30
2025-12-31	$7,295,401	35,252	-1.0%	Shares	Sole	2026-01-13
2025-09-30	$6,600,024	35,595	+0.7%	Shares	Sole	2025-11-03
2025-06-30	$5,397,879	35,338	+1.9%	Shares	Sole	2025-08-13
2025-03-31	$5,753,487	34,693	+3.7%	Shares	Sole	2025-04-11
2024-12-31	$4,839,708	33,465	+1.1%	Shares	Sole	2025-01-21
2024-09-30	$5,363,213	33,094	+0.1%	Shares	Sole	2024-10-11
2024-06-30	$4,834,242	33,075	+7.3%	Shares	Sole	2024-08-02
2024-03-31	$4,874,308	30,813	+19.8%	Shares	Sole	2024-04-23
2023-12-31	$4,031,823	25,723	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.